Key result
MAO-B inhibition plus rehabilitation improves post-stroke motor recovery and reverses cortical hypometabolism in preclinical stroke.
Glucose hypometabolism in cortical structures after functional disconnection is frequently reported in patients with white matter diseases such as subcortical stroke. However, the molecular and cellular mechanisms have been poorly elucidated. Here we show, in an animal model of internal capsular infarct, that GABA-synthesizing reactive astrocytes in distant cortical areas cause glucose hypometabolism via tonic inhibition of neighboring neurons. We find that reversal of aberrant astrocytic GABA synthesis, by pharmacological inhibition and astrocyte-specific gene silencing of MAO-B, reverses the reduction in cortical glucose metabolism. Moreover, induction of aberrant astrocytic GABA synthesis by cortical injection of putrescine or adenovirus recapitulates cortical hypometabolism. Furthermore, MAO-B inhibition causes a remarkable recovery from post-stroke motor deficits when combined with a rehabilitation regimen. Collectively, our data indicate that cortical glucose hypometabolism in subcortical stroke is caused by aberrant astrocytic GABA and MAO-B inhibition and that attenuating cortical hypometabolism can be a therapeutic approach in subcortical stroke.
No takes yet. Share an insight, caveat, or question.
Nam et al. (2020) studied Subcortical stroke. MAO-B inhibition and astrocyte-specific gene silencing of MAO-B was evaluated on Cortical glucose metabolism and post-stroke motor deficits. MAO-B inhibition reversed cortical glucose hypometabolism and, when combined with rehabilitation, improved motor recovery in an animal model of subcortical stroke.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: